U.S. Senator Johnny Isakson, R-Ga., praised President Trump’s nomination of Dr. Scott Gottlieb to serve as commissioner of the Food and Drug Administration and issued the following statement.

“Dr. Gottlieb has a strong history of both clinical and policy expertise in the field of medical innovation,” said Isakson. “His work on programs to encourage the development of new cures, generic drugs, medical countermeasures, and vaccines and his vast knowledge of health information technology make him a qualified candidate to reform the FDA and help lead the charge to bring innovative medicine and medical technology to patients in the 21^st century. I look forward to meeting Dr. Gottlieb and to participating in his confirmation hearing.”

Gottlieb’s confirmation will go through the Senate Health, Education, Labor and Pensions Committee, of which Isakson is a member.